Humana (NYSE:HUM) Given New $495.00 Price Target at Cantor Fitzgerald

Humana (NYSE:HUM) had its price objective boosted by equities research analysts at Cantor Fitzgerald from $460.00 to $495.00 in a report released on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the insurance provider’s stock. Cantor Fitzgerald‘s target price suggests a potential upside of 14.40% from the company’s current price.

Several other equities analysts have also commented on HUM. Deutsche Bank Aktiengesellschaft began coverage on shares of Humana in a research report on Thursday, July 30th. They set a “hold” rating for the company. Oppenheimer increased their price target on shares of Humana from $475.00 to $525.00 and gave the stock an “outperform” rating in a research note on Monday, October 12th. Weiss Ratings upgraded shares of Humana from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, August 14th. UBS Group boosted their price objective on shares of Humana from $405.00 to $495.00 and gave the company a “neutral” rating in a research note on Monday, October 12th. Finally, Wolfe Research restated an “outperform” rating and set a $450.00 price objective on shares of Humana in a report on Monday, August 24th. Twenty-one investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $460.48.

Humana Price Performance

HUM stock opened at $432.69 on Monday. Humana has a 52-week low of $163.11 and a 52-week high of $456.50. The stock’s fifty day simple moving average is $403.96 and its 200-day simple moving average is $312.27. The company has a quick ratio of 1.74, a current ratio of 1.65 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $51.96 billion, a price-to-earnings ratio of 42.09, a price-to-earnings-growth ratio of 2.67 and a beta of 0.65.

Humana (NYSE:HUM) last announced its quarterly earnings data on Friday, November 6th. The insurance provider reported ($0.70) EPS for the quarter, beating analysts’ consensus estimates of ($1.00) by $0.30. The business had revenue of $41.16 billion during the quarter, compared to the consensus estimate of $40.87 billion. Humana had a return on equity of 8.50% and a net margin of 0.81%. The business’s revenue for the quarter was up 26.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.24 earnings per share. Humana has set its FY 2026 guidance at 9.500- EPS. Equities research analysts expect that Humana will post 9.03 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. BlackRock Inc. acquired a new stake in shares of Humana during the 2nd quarter valued at approximately $4,138,160,000. Pzena Investment Management LLC acquired a new position in Humana in the second quarter worth $1,749,014,000. Assenagon Asset Management S.A. boosted its holdings in Humana by 20,126.8% in the third quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider’s stock worth $479,053,000 after purchasing an additional 1,249,272 shares during the period. Legal & General Group Plc acquired a new position in Humana in the second quarter worth $329,760,000. Finally, Barrow Hanley Mewhinney & Strauss LLC bought a new stake in Humana during the second quarter valued at $314,922,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans.

The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

Humana was founded in 1961 as a nursing home company and later expanded into health insurance.